Skip to main content
Signal8

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respectively. Founded in 2002, the enterprise initially operated under the name Collegium Pharmaceuticals, Inc., before officially adopting its current identity as Collegium Pharmaceutical, Inc. in October 2003. The company's corporate headquarters are situated in Stoughton, Massachusetts.

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

NASDAQ:COLLHealthcare
-0.96%$23.80
AH$23.80+0.00%vs close
Mkt Cap$774.82M
Float29.55M
O/S32.56M
Vol
$ Vol
RVOL
Inst Own-
SI18.2%
Earnings
Dilution
Financials Summary
Revenue$780.57M
Net Income$62.87M
Total Assets$1.66B
Free Cash Flow$327.58M
Debt & Equity
Debt 76%
Equity 24%
Total Debt$940.56M
Total Equity$301.68M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in COLL's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$1.66B
Liabilities$1.36B
Accounts Receivable$211.33M
Accounts Payable$10.66M
Inventory$40.91M
PP&E (Net)$16.2M
Goodwill$145.93M
Intangible Assets$669.51M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$780.57M$631.45M$566.77M$463.93M$276.87M$310.02M$296.7M$280.41M$28.48M$1.71M$0$0$0
YoY Growth23.6%11.4%22.2%67.6%-10.7%4.5%5.8%884.7%1564.3%----
Cost of Revenue$317.31M$254.1M$240.6M$254.44M$126.25M$130.18M$193.66M$165.68M$2.6M$213K$171K$0$0
Gross Profit$463.26M$377.34M$326.17M$209.49M$150.62M$179.84M$103.04M$114.74M$25.88M$1.5M-$171K$0$0
Gross Margin59.3%59.8%57.5%45.2%54.4%58.0%34.7%40.9%90.9%87.6%---
Research and Development$0$0$0$3.98M$9.45M$9.77M$10.34M$8.66M$8.57M$14.95M$7.97M$14.96M$14.16M
Selling, General, and Administrative$276.17M$182.98M$159.21M$172.19M$118.96M$113.83M$116.45M$126.76M$92.76M$80.63M$18.93M$2.71M$1.89M
Other$0$24.47M$0$0$4.58M$0$0$0$0-$94K$0$0$0
Total Operating Expenses$276.17M$207.45M$159.21M$176.17M$132.99M$123.6M$126.79M$135.42M$101.33M$95.58M$26.91M$17.66M$16.04M
Operating Income (EBIT)$187.08M$169.9M$166.96M$33.32M$17.63M$56.23M-$23.75M-$20.68M-$75.45M-$94.08M-$26.91M-$17.66M-$16.04M
Operating Margin24.0%26.9%29.5%7.2%6.4%18.1%-8.0%-7.4%-264.9%-5498.7%---
Interest Expense$82.31M$73.97M$83.34M$63.21M$21.01M$28.88M$909K$20.13M$0$94K$439K$252K$76K
Interest Income$11.29M$13.98M$15.62M$1.05M$12K$232K$1.94M$1.69M$582K$0$0$0$0
Other Income (Expense)-$94.47M-$71.33M-$91.23M-$62.17M-$21M-$28.65M$1.03M-$18.44M$582K-$94K-$348K-$252K-$155K
Income Before Tax (EBT)$92.62M$98.57M$75.73M-$28.85M-$3.37M$27.58M-$22.72M-$39.13M-$74.86M-$94.18M-$27.25M-$17.92M-$16.2M
Income Tax Expense$29.75M$29.38M$27.58M-$3.85M-$74.89M$830K$0$0$0$94K-$91K$0$79K
Net Income$62.87M$69.19M$48.16M-$25M$71.52M$26.75M-$22.72M-$39.13M-$74.86M-$94.18M-$27.25M-$17.92M-$16.2M
Net Income Margin8.1%11.0%8.5%-5.4%25.8%8.6%-7.7%-14.0%-262.9%-5504.1%---
Supplementary Data
EPS1.982.141.60-0.742.050.78-0.24-1.19-2.47-3.88-2.01-2.40-2.17
Diluted EPS1.731.861.29-0.741.860.76-0.24-1.19-2.47-3.88-2.01-2.40-2.17
Weighted Average OS31.71M32.27M33.74M33.83M34.94M34.41M33.45M32.88M30.27M24.26M13.54M7.47M7.47M
EBITDA$401M$341.7M$308.33M$173.31M$86.56M$118.01M-$6.33M$91.91M-$74.27M-$93.43M-$26.64M-$17.48M-$15.95M
EBITDA Margin51.4%54.1%54.4%37.4%31.3%38.1%-2.1%32.8%-260.8%-5460.4%---
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$251.1M$70.56M$238.95M$173.69M$186.43M$174.12M$170.02M$146.63M$118.7M$153.22M$95.7M$1.63M$7.55M
Short-Term Investments$155.43M$92.2M$71.6M$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$406.53M$162.76M$310.55M$173.69M$186.43M$174.12M$170.02M$146.63M$118.7M$153.22M$95.7M$1.63M$7.55M
Accounts Receivable$211.33M$228.54M$179.53M$183.12M$105.84M$83.32M$72.95M$77.95M$9.97M$2.13M$0$0$0
Inventory$40.91M$35.56M$32.33M$46.5M$17.39M$15.61M$9.64M$7.82M$1.81M$1.32M$0$0$0
Other Current Assets$3.24M$27.74M$93K$57K$27K$60K$141K$1.01M$456K$304K$558K$2.82M$0
Total Current Assets$691.41M$482.26M$537.6M$419.99M$315.54M$277.89M$255.72M$237.51M$133.48M$158.57M$96.88M$4.5M$8.26M
Long-Term Assets
Property, Plant & Equipment Net$16.2M$20.15M$22.01M$26.38M$27.14M$27.38M$20.9M$9.27M$1.83M$1.04M$738K$514K$693K
Goodwill$145.93M$162.33M$133.86M$133.69M$0$0$0$0$0$0$0$0$0
Intangible Assets$669.51M$891.4M$421.71M$567.47M$268.72M$335.9M$29.5M$44.26M$0$2.1M$0$0$0
Long-Term Investments$1.06M$0$0$2.55M$2.55M$0$0$0$97K$97K$97K$0$0
Deferred Tax Assets$112.54M$98.03M$26.26M$23.95M$78.04M$0$0$0$0-$97K$0$0$0
Other Long-Term Assets$20.19M$9.41M$1.87M$100K$87K$2.67M$178K$204K$161K$301K$0$80K$80K
Total Long-Term Assets$965.42M$1.18B$605.71M$754.14M$376.53M$365.95M$50.58M$53.73M$2.08M$3.44M$835K$594K$773K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$1.66B$1.66B$1.14B$1.17B$692.08M$643.84M$306.3M$291.25M$135.57M$162.02M$97.72M$5.09M$9.03M
Liabilities
Current Liabilities
Accounts Payable$10.66M$3.93M$8.69M$3.49M$4.19M$10.02M$6.25M$12.15M$5.68M$9.11M$3.54M$2.21M$1.22M
Short-Term Debt$30.41M$64.58M$183.33M$162.5M$48.35M$47.49M$3.83M$1.64M$1.48M$2.67M$2.67M$6.19M$333K
Current Income Tax Payable$0$15.19M$7.15M$4.35M$3.19M$1.82M$0$0$0$0$0$0$0
Current Unearned Revenue$667K$0$988K$0$0$0$0$0$0$4.94M-$9.55M$0$0
Other Current Liabilities$378.73M$7.61M$253.91M$1.51M$851K$1.42M$5.7M$167.7M$18.21M$4.29M$661K$1.38M$619K
Total Current Liabilities$440.03M$509.51M$457.92M$433.73M$279.57M$239.45M$201.76M$187.48M$31.49M$22.93M$5.76M$10.42M$2.62M
Long-Term Liabilities
Long-Term Debt$906.02M$787.9M$483.84M$538.45M$201.63M$209.59M$7.67M$9.86M$0$1.48M$4.15M$6.81M$640K
Long-Term Unearned Revenue$9.11M$10M$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities-$4.13M$121.8M$0$0$0$0$0$676K$0$0$0$0$59K
Total Long-Term Liabilities$915.13M$925.24M$489.96M$545.56M$209.58M$218.36M$17.11M$12.18M$7.16M$4.18M$6.88M$6.91M$834K
Other Liabilities$0$0$0$0$0$0$0$0-$7.16M$0$0$0$0
Total Liabilities$1.36B$1.43B$947.88M$979.29M$489.15M$457.81M$218.87M$199.66M$31.49M$27.11M$12.65M$17.33M$3.45M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$77.11M$73.81M
Common Stock$41K$40K$38K$37K$36K$35K$34K$33K$33K$29K$21K$8K$1K
Retained Earnings-$101.13M-$164M-$233.19M-$281.34M-$256.34M-$333.15M-$359.9M-$337.18M-$298.05M-$223.18M-$129.01M-$101.75M-$80.54M
Comprehensive Income & Other$319K$55K$14K$0$0$0$0$0-$1.67M-$1.33M-$1.07M-$903K-$716K
Other Stockholders' Equity$402.76M$392.8M$428.58M$476.15M$459.23M$519.14M$447.3M$428.73M$402.1M$358.06M$214.06M$89.5M$86.12M
Total Equity$301.68M$228.84M$195.43M$194.84M$202.93M$186.03M$87.43M$91.58M$104.08M$134.91M$85.07M-$12.24M$5.58M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$1.66B$1.66B$1.14B$1.17B$692.08M$643.84M$306.3M$291.25M$135.57M$162.02M$97.72M$5.09M$9.03M
Supplementary Data
Total Debt$940.56M$859.3M$674.28M$709.17M$258.75M$266.58M$21.59M$11.5M$1.48M$4.15M$6.81M$13.01M$973K
Net Debt$689.46M$788.73M$435.34M$535.49M$72.32M$92.47M-$148.43M-$135.13M-$117.22M-$149.08M-$88.88M$11.37M-$6.58M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income$62.87M$69.19M$48.16M-$25M$71.52M$26.75M-$22.72M-$39.13M-$74.86M-$94.18M-$27.25M-$17.92M-$16.2M
Depreciation & Amortization$226.07M$169.16M$149.26M$138.94M$68.92M$61.55M$15.48M$110.91M$594K$655K$171K$187K$169K
Deferred Income Tax-$25.66M-$26.81M-$2.15M-$8.39M-$78.04M$0$0$0$1.84M$0$0$0$79K
Stock-Based Compensation$41.91M$32.4M$27.14M$22.87M$24.25M$21.91M$16.53M$13.78M$7.95M$5.79M$2.21M$22K$62K
Changes in Working Capital:
  Accounts Receivable$17.2M-$4.41M$3.59M-$21.78M-$22.52M-$10.37M$4.99M-$68.23M-$7.84M-$2.13M$0$0$0
  Inventory-$5.35M$13.93M$14.17M$48.27M-$2.3M-$8.27M-$1.83M$219K-$497K-$1.32M$0$0$0
  Accounts Payable$6.72M-$11.28M$5.06M-$707K-$5.83M$3.77M$0$6.46M-$3.42M$5.57M$1.3M$990K-$822K
  Other Working Capital-$14.81M-$53.21M-$1.09M-$38.5M$44.13M-$10.43M$20.92M$126.1M$9.26M$10.59M$2.04M-$1.21M$188K
Total Working Capital Change$3.76M-$54.98M$21.73M-$12.71M$13.49M-$25.3M$24.08M$64.55M-$2.5M$12.71M$3.34M-$219K-$634K
Other Non-Cash Items$20.37M$16.02M$30.62M$8.52M$3.42M$9.03M-$5.59M$19.28M-$34K-$34K-$28K-$20K-$9K
Net Cash from Operating$329.32M$204.98M$274.75M$124.23M$103.56M$93.94M$27.78M$169.39M-$67.02M-$75.05M-$21.57M-$17.95M-$16.53M
Investing Activities
Capital Expenditures-$1.74M-$1.65M-$461K-$1.62M-$1.94M-$5.55M-$6.44M-$24.35M-$990K-$2.98M-$362K-$8K-$206K
Acquisitions$0-$267.54M$0-$572.07M$0$0$0$0$0$0$0$0$0
Purchases of Investments-$126.97M-$111.17M-$92.35M$0$0$0$0$0$0$0$0$0$0
Sales of Investments$65.18M$92.6M$22M$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0-$368.23M$0-$18.88M$0-$2.5M$0$0$0
Net Cash from Investing-$63.53M-$287.76M-$70.81M-$573.69M-$1.94M-$373.77M-$6.44M-$24.35M-$990K-$2.98M-$362K-$8K-$206K
Financing Activities
Debt Repaid$70.38M-$7.52M$65.92M-$442.68M$50M-$281.39M--$10.02M$2.67M$2.67M$1.34M-$6.97M-$395K
Common Stock Issuance$5.64M$0$0$0$0$0$0-$30K$34.34M$137.34M$72.03M$0$0
Common Stock Repurchases-$25.1M-$60.02M-$75M-$14.06M-$47.86M$0-$822K-$560K$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0-$24.57M$0$0
Other Financing Activities-$20.4M-$8.1M$740K$8.1M$8.56M$5.08M$2.86M-$127.19M$1.81M$885K$25.07M$72K$1K
Net Cash from Financing-$110.25M-$60.6M-$140.18M$436.72M-$89.3M$286.47M$2.04M-$117.2M$33.48M$135.56M$115.99M$12.04M$12.35M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$155.55M-$143.38M$63.76M-$12.74M$12.31M$6.64M$23.39M$27.84M-$34.53M$57.53M$94.06M-$5.92M-$4.38M
Supplementary Data
Operating Cash Flow$329.32M$204.98M$274.75M$124.23M$103.56M$93.94M$27.78M$169.39M-$67.02M-$75.05M-$21.57M-$17.95M-$16.53M
Capital Expenditure-$1.74M-$1.65M-$461K-$1.62M-$1.94M-$373.77M-$6.44M-$24.35M-$990K-$2.98M-$362K-$8K-$206K
Free Cash Flow$327.58M$203.33M$274.29M$122.61M$101.61M-$279.83M$21.34M$145.04M-$68.01M-$78.03M-$21.93M-$17.95M-$16.74M
Cash at Beginning$96.61M$239.99M$176.24M$188.97M$176.66M$170.02M$146.63M$118.79M$153.22M$95.7M$1.63M$7.55M$11.94M
Cash at End$252.16M$96.61M$239.99M$176.24M$188.97M$176.66M$170.02M$146.63M$118.7M$153.22M$95.7M$1.63M$7.55M